Mechanism of Drug-Drug Interactions Mediated by Human Cytochrome P450 CYP3A4 Monomer

Ilia G. Denisov, Yelena V. Grinkova, Javier L. Baylon, Emad Tajkhorshid, Stephen G. Sligar

Research output: Contribution to journalArticle

Abstract

Using Nanodiscs, we quantitate the heterotropic interaction between two different drugs mediated by monomeric CYP3A4 incorporated into a nativelike membrane environment. The mechanism of this interaction is deciphered by global analysis of multiple-turnover experiments performed under identical conditions using the pure substrates progesterone (PGS) and carbamazepine (CBZ) and their mixtures. Activation of CBZ epoxidation and simultaneous inhibition of PGS hydroxylation are measured and quantitated through differences in their respective affinities for both a remote allosteric site and the productive catalytic site near the heme iron. Preferred binding of PGS at the allosteric site and a stronger preference for CBZ binding at the productive site give rise to a nontrivial drug-drug interaction. Molecular dynamics simulations indicate functionally important conformational changes caused by PGS binding at the allosteric site and by two CBZ molecules positioned inside the substrate binding pocket. Structural changes involving Phe-213, Phe-219, and Phe-241 are thought to be responsible for the observed synergetic effects and positive allosteric interactions between these two substrates. Such a mechanism is likely of general relevance to the mutual heterotropic effects caused by biologically active compounds that exhibit different patterns of interaction with the distinct allosteric and productive sites of CYP3A4, as well as other xenobiotic metabolizing cytochromes P450 that are also involved in drug-drug interactions. Importantly, this work demonstrates that a monomeric CYP3A4 can display the full spectrum of activation and cooperative effects that are observed in hepatic membranes. (Chemical Equation Presented).

Original languageEnglish (US)
Pages (from-to)2227-2239
Number of pages13
JournalBiochemistry
Volume54
Issue number13
DOIs
StatePublished - Apr 7 2015

Fingerprint

Drug interactions
Allosteric Site
Cytochrome P-450 CYP3A
Carbamazepine
Drug Interactions
Cytochrome P-450 Enzyme System
Progesterone
Monomers
Pharmaceutical Preparations
Substrates
Chemical activation
Membranes
Hydroxylation
Epoxidation
Xenobiotics
Molecular Dynamics Simulation
Heme
Molecular dynamics
Catalytic Domain
Iron

ASJC Scopus subject areas

  • Biochemistry

Cite this

Mechanism of Drug-Drug Interactions Mediated by Human Cytochrome P450 CYP3A4 Monomer. / Denisov, Ilia G.; Grinkova, Yelena V.; Baylon, Javier L.; Tajkhorshid, Emad; Sligar, Stephen G.

In: Biochemistry, Vol. 54, No. 13, 07.04.2015, p. 2227-2239.

Research output: Contribution to journalArticle

Denisov, Ilia G. ; Grinkova, Yelena V. ; Baylon, Javier L. ; Tajkhorshid, Emad ; Sligar, Stephen G. / Mechanism of Drug-Drug Interactions Mediated by Human Cytochrome P450 CYP3A4 Monomer. In: Biochemistry. 2015 ; Vol. 54, No. 13. pp. 2227-2239.
@article{6c15bfb4791b4fe4b93e708302e441ef,
title = "Mechanism of Drug-Drug Interactions Mediated by Human Cytochrome P450 CYP3A4 Monomer",
abstract = "Using Nanodiscs, we quantitate the heterotropic interaction between two different drugs mediated by monomeric CYP3A4 incorporated into a nativelike membrane environment. The mechanism of this interaction is deciphered by global analysis of multiple-turnover experiments performed under identical conditions using the pure substrates progesterone (PGS) and carbamazepine (CBZ) and their mixtures. Activation of CBZ epoxidation and simultaneous inhibition of PGS hydroxylation are measured and quantitated through differences in their respective affinities for both a remote allosteric site and the productive catalytic site near the heme iron. Preferred binding of PGS at the allosteric site and a stronger preference for CBZ binding at the productive site give rise to a nontrivial drug-drug interaction. Molecular dynamics simulations indicate functionally important conformational changes caused by PGS binding at the allosteric site and by two CBZ molecules positioned inside the substrate binding pocket. Structural changes involving Phe-213, Phe-219, and Phe-241 are thought to be responsible for the observed synergetic effects and positive allosteric interactions between these two substrates. Such a mechanism is likely of general relevance to the mutual heterotropic effects caused by biologically active compounds that exhibit different patterns of interaction with the distinct allosteric and productive sites of CYP3A4, as well as other xenobiotic metabolizing cytochromes P450 that are also involved in drug-drug interactions. Importantly, this work demonstrates that a monomeric CYP3A4 can display the full spectrum of activation and cooperative effects that are observed in hepatic membranes. (Chemical Equation Presented).",
author = "Denisov, {Ilia G.} and Grinkova, {Yelena V.} and Baylon, {Javier L.} and Emad Tajkhorshid and Sligar, {Stephen G.}",
year = "2015",
month = "4",
day = "7",
doi = "10.1021/acs.biochem.5b00079",
language = "English (US)",
volume = "54",
pages = "2227--2239",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "13",

}

TY - JOUR

T1 - Mechanism of Drug-Drug Interactions Mediated by Human Cytochrome P450 CYP3A4 Monomer

AU - Denisov, Ilia G.

AU - Grinkova, Yelena V.

AU - Baylon, Javier L.

AU - Tajkhorshid, Emad

AU - Sligar, Stephen G.

PY - 2015/4/7

Y1 - 2015/4/7

N2 - Using Nanodiscs, we quantitate the heterotropic interaction between two different drugs mediated by monomeric CYP3A4 incorporated into a nativelike membrane environment. The mechanism of this interaction is deciphered by global analysis of multiple-turnover experiments performed under identical conditions using the pure substrates progesterone (PGS) and carbamazepine (CBZ) and their mixtures. Activation of CBZ epoxidation and simultaneous inhibition of PGS hydroxylation are measured and quantitated through differences in their respective affinities for both a remote allosteric site and the productive catalytic site near the heme iron. Preferred binding of PGS at the allosteric site and a stronger preference for CBZ binding at the productive site give rise to a nontrivial drug-drug interaction. Molecular dynamics simulations indicate functionally important conformational changes caused by PGS binding at the allosteric site and by two CBZ molecules positioned inside the substrate binding pocket. Structural changes involving Phe-213, Phe-219, and Phe-241 are thought to be responsible for the observed synergetic effects and positive allosteric interactions between these two substrates. Such a mechanism is likely of general relevance to the mutual heterotropic effects caused by biologically active compounds that exhibit different patterns of interaction with the distinct allosteric and productive sites of CYP3A4, as well as other xenobiotic metabolizing cytochromes P450 that are also involved in drug-drug interactions. Importantly, this work demonstrates that a monomeric CYP3A4 can display the full spectrum of activation and cooperative effects that are observed in hepatic membranes. (Chemical Equation Presented).

AB - Using Nanodiscs, we quantitate the heterotropic interaction between two different drugs mediated by monomeric CYP3A4 incorporated into a nativelike membrane environment. The mechanism of this interaction is deciphered by global analysis of multiple-turnover experiments performed under identical conditions using the pure substrates progesterone (PGS) and carbamazepine (CBZ) and their mixtures. Activation of CBZ epoxidation and simultaneous inhibition of PGS hydroxylation are measured and quantitated through differences in their respective affinities for both a remote allosteric site and the productive catalytic site near the heme iron. Preferred binding of PGS at the allosteric site and a stronger preference for CBZ binding at the productive site give rise to a nontrivial drug-drug interaction. Molecular dynamics simulations indicate functionally important conformational changes caused by PGS binding at the allosteric site and by two CBZ molecules positioned inside the substrate binding pocket. Structural changes involving Phe-213, Phe-219, and Phe-241 are thought to be responsible for the observed synergetic effects and positive allosteric interactions between these two substrates. Such a mechanism is likely of general relevance to the mutual heterotropic effects caused by biologically active compounds that exhibit different patterns of interaction with the distinct allosteric and productive sites of CYP3A4, as well as other xenobiotic metabolizing cytochromes P450 that are also involved in drug-drug interactions. Importantly, this work demonstrates that a monomeric CYP3A4 can display the full spectrum of activation and cooperative effects that are observed in hepatic membranes. (Chemical Equation Presented).

UR - http://www.scopus.com/inward/record.url?scp=84926678754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926678754&partnerID=8YFLogxK

U2 - 10.1021/acs.biochem.5b00079

DO - 10.1021/acs.biochem.5b00079

M3 - Article

C2 - 25777547

AN - SCOPUS:84926678754

VL - 54

SP - 2227

EP - 2239

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 13

ER -